Literature DB >> 12646776

Value of diffusion-weighted imaging in patients with a nonlocalizing examination and vasospasm from subarachnoid hemorrhage.

Thanh G Phan1, John Huston, Norbert G Campeau, Eelco F M Wijdicks, John L D Atkinson, Jimmy R Fulgham.   

Abstract

We evaluated the value of diffusion-weighted imaging (DWI) in patients with suspected vasospasm from subarachnoid hemorrhage (SAH). Magnetic resonance imaging (MRI), including DWI, was performed in 5 patients with vasospasm resulting from SAH. Restricted diffusion (ischemia) was present in 3 patients with symptomatic vasospasm. A diffusion abnormality was not demonstrated in 2 patients with asymptomatic vasospasm despite persistently elevated velocities by transcranial Doppler ultrasonography in 1. In this patient, serial MRI studies showed no ischemia. Our results suggest that DWI may provide a method to assess the presence and severity of ischemia in patients with SAH and vasospasm and assist in patient management. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12646776     DOI: 10.1159/000068823

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  3 in total

1.  Acute ischemic injury on diffusion-weighted magnetic resonance imaging after poor grade subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; Sheetal J Sheth; J Michael Schmidt; Jennifer A Frontera; Fred Rincon; Noeleen Ostapkovich; Luis Fernandez; Neeraj Badjatia; E Sander Connolly; Alexander Khandji; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

2.  Ruptured AComA aneurysm and asymptomatic bilateral ACA vasospasm in an infant: surgical case report.

Authors:  Cristina Caterina Aldea; Ioan Alexandru Florian; Teodora Larisa Timiș; Zorinela Andrașoni; Ioan Stefan Florian
Journal:  Childs Nerv Syst       Date:  2021-05-21       Impact factor: 1.475

Review 3.  Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.

Authors:  Salah G Keyrouz; Michael N Diringer
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.